Physician

Michael A. Stipanov, MD

According to 2025 Medicare claims, Michael Stipanov, MD (NPI: 1255384616) practices hematology/oncology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 37343-6614. Stipanov is affiliated with the Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Stipanov's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 676 traditional Medicare patients, billed 200,911 HCPCS/CPT codes, and received $4,437,856 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,582 prescription claims across 372 beneficiaries totaling $10,263,995 in drug costs, led by Revlimid (Lenalidomide). DME data shows 12 claims. Open Payments data shows 2 records totaling $41. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,035,772 to $4,437,856. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,156,665 to $10,263,995. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.3M$4.6M2015 Medicare payment: $2,035,772 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,637,362 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,150,785 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,384,198 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,466,734 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,558,097 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,383,787 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,164,781 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,909,973 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,437,856 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015696183,639$2,035,772
2016690235,443$2,637,362
2017692296,547$3,150,785
2018630305,006$3,384,198
2019610258,736$4,466,734
2020614284,359$4,558,097
2021648260,772$4,383,787
2022659194,449$3,164,781
2023682258,988$3,909,973
2024676200,911$4,437,856

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.1M$10M2015 Drug cost: $2,156,665 (USD; Tot_Drug_Cst)2016 Drug cost: $3,843,074 (USD; Tot_Drug_Cst)2017 Drug cost: $3,649,852 (USD; Tot_Drug_Cst)2018 Drug cost: $4,506,490 (USD; Tot_Drug_Cst)2019 Drug cost: $5,586,895 (USD; Tot_Drug_Cst)2020 Drug cost: $6,022,219 (USD; Tot_Drug_Cst)2021 Drug cost: $7,677,367 (USD; Tot_Drug_Cst)2022 Drug cost: $7,278,853 (USD; Tot_Drug_Cst)2023 Drug cost: $7,671,636 (USD; Tot_Drug_Cst)2024 Drug cost: $10,263,995 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152851,994$2,156,665
20163182,376$3,843,074
20172942,126$3,649,852
20183202,366$4,506,490
20193272,224$5,586,895
20203001,961$6,022,219
20213002,048$7,677,367
20223342,143$7,278,853
20233512,365$7,671,636
20243722,582$10,263,995

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.9K$14K2015 Medicare payment: $5,260 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $1,380 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $11,398 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $5,906 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $8,144 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,723 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,060 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $13,726 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,007 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R115$5,260
2016N/R53$1,380
2017N/R48$11,398
2018N/R35$5,906
2019N/R50$8,144
2020N/R54$4,723
2021N/R29$2,060
2022N/RN/RN/R
2023N/R59$13,726
2024N/R12$2,007

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3821,051$86
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's276509$12
80053Blood test, comprehensive group of blood chemicals4461,755$10
36415Insertion of needle into vein for collection of blood sample4671,954$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4892,533$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide1413,921$2,342,244
BrukinsaZanubrutinib902,700$1,212,234
CalquenceAcalabrutinib Maleate531,590$811,670
IbrancePalbociclib541,512$784,389
VerzenioAbemaciclib521,456$777,859

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
B4035Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tapeNN/R12$2,007

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$41Gilead Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael A. Stipanov, MD?

Tedicare shows public-source Medicare data for Michael A. Stipanov, MD (NPI 1255384616), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael A. Stipanov, MD have ACO affiliation data?

Michael A. Stipanov, MD is shown with ACO affiliation data for Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Michael A. Stipanov, MD?

Michael A. Stipanov, MD is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does Michael A. Stipanov, MD have Open Payments data?

Michael A. Stipanov, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.